PARADIGM ASSET MANAGEMENT CO LLC - Astellas Pharma Inc ownership

Back to all holdings Add to watchlist

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 5 filers reported holding Astellas Pharma Inc in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
PARADIGM ASSET MANAGEMENT CO LLC ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q2 2023$37,175
+4.8%
2,5000.0%0.01%0.0%
Q1 2023$35,487
-6.4%
2,5000.0%0.01%
-9.1%
Q4 2022$37,900
-99.9%
2,5000.0%0.01%0.0%
Q3 2022$33,325,000–2,500–0.01%–
 Download
Other shareholders
Astellas Pharma Inc shareholders Q3 2022
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 391,745$5,438,8800.25%
Cassady Schiller Wealth Management, LLC 698$9,6670.01%
MAI Capital Management 19,087$264,3620.00%
SVB WEALTH LLC 10,472$145,0370.00%
RHUMBLINE ADVISERS 34,759$481,4080.00%
First Horizon Advisors, Inc. 114$1,5780.00%
Operose Advisors LLC 90$1,2470.00%
Russell Investments Group, Ltd. 783$10,8450.00%
PNC FINANCIAL SERVICES GROUP, INC. 166$2,2990.00%
View complete list of Astellas Pharma Inc shareholders